Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,571 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission.
Yanada M, Yamasaki S, Kondo T, Kawata T, Harada K, Uchida N, Doki N, Yoshihara S, Katayama Y, Eto T, Tanaka M, Takada S, Kawakita T, Nishida T, Ota S, Serizawa K, Onizuka M, Kanda Y, Fukuda T, Atsuta Y, Konuma T. Yanada M, et al. Among authors: ota s. Leukemia. 2024 Mar;38(3):513-520. doi: 10.1038/s41375-023-02119-0. Epub 2023 Dec 21. Leukemia. 2024. PMID: 38129514
Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy.
Arai Y, Takeda J, Aoki K, Kondo T, Takahashi S, Onishi Y, Ozawa Y, Aotsuka N, Kouzai Y, Nakamae H, Ota S, Nakaseko C, Yamaguchi H, Kato K, Atsuta Y, Takami A; AML and MDS Working Group of the Japan Society for Hematopoietic Cell Transplantation. Arai Y, et al. Among authors: ota s. Blood. 2015 Jul 16;126(3):415-22. doi: 10.1182/blood-2015-04-642652. Epub 2015 Jun 1. Blood. 2015. PMID: 26031916 Free PMC article.
Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy.
Arai Y, Aoki K, Takeda J, Kondo T, Eto T, Ota S, Hashimoto H, Fukuda T, Ozawa Y, Kanda Y, Kato C, Kurokawa M, Iwato K, Onizuka M, Ichinohe T, Atsuta Y, Takami A; AML and MDS Working Group of Japan Society for Hematopoietic Cell Transplantation. Arai Y, et al. Among authors: ota s. J Hematol Oncol. 2015 Sep 4;8:102. doi: 10.1186/s13045-015-0201-x. J Hematol Oncol. 2015. PMID: 26337829 Free PMC article.
Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study).
Nakasone H, Terasako-Saito K, Hirano T, Wake A, Shimizu S, Kurita N, Yamazaki E, Usuki K, Akazawa K, Kanda J, Minauchi K, Yamamoto G, Tanimoto S, Kamoshita M, Yokoyama Y, Miyaoka E, Ota S, Kako S, Izutsu K, Kanda Y. Nakasone H, et al. Among authors: ota s. Hematol Oncol. 2018 Feb;36(1):202-209. doi: 10.1002/hon.2452. Epub 2017 Jul 6. Hematol Oncol. 2018. PMID: 28681529
Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients.
Yanada M, Mori J, Aoki J, Harada K, Mizuno S, Uchida N, Kurosawa S, Toya T, Kanamori H, Ozawa Y, Ogawa H, Henzan H, Iwato K, Sakura T, Ota S, Fukuda T, Ichinohe T, Atsuta Y, Yano S. Yanada M, et al. Among authors: ota s. Leuk Lymphoma. 2018 Mar;59(3):601-609. doi: 10.1080/10428194.2017.1357173. Epub 2017 Jul 28. Leuk Lymphoma. 2018. PMID: 28750566
Outcomes after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia harboring t(7;11)(p15;p15).
Harada K, Doki N, Aoki J, Mori J, Machida S, Masuko M, Uchida N, Najima Y, Fukuda T, Kanamori H, Ogawa H, Ota S, Ogawa K, Takahashi S, Kasai M, Maeda A, Nagafuji K, Kawakita T, Ichinohe T, Atsuta Y. Harada K, et al. Among authors: ota s. Haematologica. 2018 Feb;103(2):e69-e72. doi: 10.3324/haematol.2017.179804. Epub 2017 Nov 16. Haematologica. 2018. PMID: 29146707 Free PMC article. No abstract available.
Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data.
Yoshinaga N, Kanda J, Aisa Y, Hagiwara S, Mori T, Fukuda T, Ishida Y, Hashimoto H, Iwato K, Kanda Y, Kurokawa M, Nakazawa H, Ota S, Uchida N, Ichinohe T, Atsuta Y, Takaori-Kondo A. Yoshinaga N, et al. Among authors: ota s. Biol Blood Marrow Transplant. 2018 Aug;24(8):1596-1601. doi: 10.1016/j.bbmt.2018.03.009. Epub 2018 Mar 15. Biol Blood Marrow Transplant. 2018. PMID: 29551446 Free article.
Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT).
Konuma T, Yanada M, Yamasaki S, Kuwatsuka Y, Fukuda T, Kobayashi T, Ozawa Y, Uchida N, Ota S, Hoshino T, Takahashi S, Kanda Y, Ueda Y, Takanashi M, Kanda J, Ichinohe T, Atsuta Y, Yano S. Konuma T, et al. Among authors: ota s. Br J Haematol. 2018 Jul;182(2):245-250. doi: 10.1111/bjh.15399. Epub 2018 May 29. Br J Haematol. 2018. PMID: 29808919 Free article.
Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).
Konuma T, Mizuno S, Kondo T, Yamaguchi H, Fukuda T, Uchida N, Najima Y, Kanamori H, Ota S, Nakamae H, Nakamae M, Mizuno I, Sugita J, Onishi Y, Yokota A, Takahashi S, Kanda Y, Ichinohe T, Atsuta Y, Yano S; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Konuma T, et al. Among authors: ota s. Ann Hematol. 2018 Nov;97(11):2173-2183. doi: 10.1007/s00277-018-3419-1. Epub 2018 Jul 6. Ann Hematol. 2018. PMID: 29978286 Clinical Trial.
1,571 results